235 related articles for article (PubMed ID: 22687263)
1. Surveillance for ocular hypertension: an evidence synthesis and economic evaluation.
Burr JM; Botello-Pinzon P; Takwoingi Y; Hernández R; Vazquez-Montes M; Elders A; Asaoka R; Banister K; van der Schoot J; Fraser C; King A; Lemij H; Sanders R; Vernon S; Tuulonen A; Kotecha A; Glasziou P; Garway-Heath D; Crabb D; Vale L; Azuara-Blanco A; Perera R; Ryan M; Deeks J; Cook J
Health Technol Assess; 2012 Jun; 16(29):1-271, iii-iv. PubMed ID: 22687263
[TBL] [Abstract][Full Text] [Related]
2. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
3. Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective.
Hernández R; Burr JM; Vale L; Azuara-Blanco A; Cook JA; Banister K; Tuulonen A; Ryan M;
Br J Ophthalmol; 2016 Sep; 100(9):1263-8. PubMed ID: 26659710
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of treating ocular hypertension.
Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
[TBL] [Abstract][Full Text] [Related]
5. The European glaucoma prevention study design and baseline description of the participants.
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
Ophthalmology; 2002 Sep; 109(9):1612-21. PubMed ID: 12208707
[TBL] [Abstract][Full Text] [Related]
6. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.
King AJ; Rotchford AP
JAMA Ophthalmol; 2016 Jul; 134(7):742-7. PubMed ID: 27148831
[TBL] [Abstract][Full Text] [Related]
7. Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches.
Orme M; Collins S; Loftus J
J Glaucoma; 2012 Sep; 21(7):433-49. PubMed ID: 21677590
[TBL] [Abstract][Full Text] [Related]
8. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma.
Medeiros FA; Weinreb RN; Zangwill LM; Alencar LM; Sample PA; Vasile C; Bowd C
Ophthalmology; 2008 Jun; 115(6):934-40. PubMed ID: 17936908
[TBL] [Abstract][Full Text] [Related]
9. The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension.
van Gestel A; Schouten JS; Beckers HJ; Severens JL; Hendrikse F; Webers CA
Acta Ophthalmol; 2014 Sep; 92(6):513-23. PubMed ID: 24330516
[TBL] [Abstract][Full Text] [Related]
10. [Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].
Ge J; Li X; Sun X; He X; Zhang H
Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):95-102. PubMed ID: 25907999
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
Noecker RJ; Walt JG
Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
[TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.
Burr JM; Mowatt G; Hernández R; Siddiqui MA; Cook J; Lourenco T; Ramsay C; Vale L; Fraser C; Azuara-Blanco A; Deeks J; Cairns J; Wormald R; McPherson S; Rabindranath K; Grant A
Health Technol Assess; 2007 Oct; 11(41):iii-iv, ix-x, 1-190. PubMed ID: 17927922
[TBL] [Abstract][Full Text] [Related]
14. Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
Kymes SM; Kass MA; Anderson DR; Miller JP; Gordon MO;
Am J Ophthalmol; 2006 Jun; 141(6):997-1008. PubMed ID: 16765666
[TBL] [Abstract][Full Text] [Related]
15. More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England.
Boodhna T; Crabb DP
BMC Health Serv Res; 2016 Oct; 16(1):611. PubMed ID: 27770792
[TBL] [Abstract][Full Text] [Related]
16. Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension.
Plosker GL; Keam SJ
Pharmacoeconomics; 2006; 24(3):297-314. PubMed ID: 16519552
[TBL] [Abstract][Full Text] [Related]
17. Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: strategies, clinical outcomes, and costs at 1 year.
Rouland JF; Le Pen C;
Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S5-20. PubMed ID: 12948049
[TBL] [Abstract][Full Text] [Related]
18. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Kass MA; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Gordon MO
Arch Ophthalmol; 2002 Jun; 120(6):701-13; discussion 829-30. PubMed ID: 12049574
[TBL] [Abstract][Full Text] [Related]
19. The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
van Gestel A; Webers CA; Severens JL; Beckers HJ; Jansonius NM; Hendrikse F; Schouten JS
Acta Ophthalmol; 2012 Feb; 90(1):20-31. PubMed ID: 22289192
[TBL] [Abstract][Full Text] [Related]
20. Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.
Brandt JD; Gordon MO; Gao F; Beiser JA; Miller JP; Kass MA;
Ophthalmology; 2012 Mar; 119(3):437-42. PubMed ID: 21705084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
